These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 26431981)
1. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years. Petráš M; Adámková V Vaccine; 2015 Nov; 33(46):6264-7. PubMed ID: 26431981 [TBL] [Abstract][Full Text] [Related]
2. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. Mariani L; Vici P; Suligoi B; Checcucci-Lisi G; Drury R Adv Ther; 2015 Jan; 32(1):10-30. PubMed ID: 25620536 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. Dominiak-Felden G; Gobbo C; Simondon F PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096 [TBL] [Abstract][Full Text] [Related]
4. Rates and predictors of genital warts burden in the Czech population. Petráš M; Adámková V Int J Infect Dis; 2015 Jun; 35():29-33. PubMed ID: 25869075 [TBL] [Abstract][Full Text] [Related]
5. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls. Blomberg M; Dehlendorff C; Sand C; Kjaer SK Clin Infect Dis; 2015 Sep; 61(5):676-82. PubMed ID: 25944340 [TBL] [Abstract][Full Text] [Related]
6. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes. Sonnenberg P; Tanton C; Mesher D; King E; Beddows S; Field N; Mercer CH; Soldan K; Johnson AM Sex Transm Infect; 2019 Aug; 95(5):386-390. PubMed ID: 30723185 [TBL] [Abstract][Full Text] [Related]
8. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Blomberg M; Dehlendorff C; Munk C; Kjaer SK Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192 [TBL] [Abstract][Full Text] [Related]
9. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210 [TBL] [Abstract][Full Text] [Related]
10. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. Oliphant J; Perkins N N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330 [TBL] [Abstract][Full Text] [Related]
11. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. Kjaer SK; Tran TN; Sparen P; Tryggvadottir L; Munk C; Dasbach E; Liaw KL; Nygård J; Nygård M J Infect Dis; 2007 Nov; 196(10):1447-54. PubMed ID: 18008222 [TBL] [Abstract][Full Text] [Related]
12. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity. Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039 [TBL] [Abstract][Full Text] [Related]
13. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728 [TBL] [Abstract][Full Text] [Related]
14. Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women. Bollerup S; Baldur-Felskov B; Blomberg M; Baandrup L; Dehlendorff C; Kjaer SK Sex Transm Dis; 2016 Apr; 43(4):238-42. PubMed ID: 26967300 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Llata E; Stenger M; Bernstein K; Guerry S; Kerani R; Pugsley R; Pathela P; Tabidze I; Weinstock H; Sex Transm Dis; 2014 Feb; 41(2):89-93. PubMed ID: 24413486 [TBL] [Abstract][Full Text] [Related]
16. What can surveillance of genital warts tell us? Fairley CK; Donovan B Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222 [TBL] [Abstract][Full Text] [Related]
17. The incidence of genital warts in Australian women prior to the national vaccination program. Brotherton JM; Heywood A; Heley S Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953 [TBL] [Abstract][Full Text] [Related]
18. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011. Liu B; Donovan B; Brotherton JM; Saville M; Kaldor JM Sex Transm Infect; 2014 Nov; 90(7):532-7. PubMed ID: 24570485 [TBL] [Abstract][Full Text] [Related]
19. Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study. Willows K; Bozat-Emre S; Righolt CH; Kliewer EV; Mahmud SM Sex Transm Dis; 2018 Apr; 45(4):254-259. PubMed ID: 29465699 [TBL] [Abstract][Full Text] [Related]
20. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study. Baandrup L; Dehlendorff C; Kjaer SK Clin Infect Dis; 2021 Nov; 73(9):e3220-e3226. PubMed ID: 33048118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]